Lidocaine Hydrochloride Injection, Solution
NDC Package 85766-187-25

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lidocaine Hydrochloride (lidocaine hydrochloride anhydrous) injection is lidocaine HCl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. This formulation utilizes a injection, solution delivery system. Marketed by Sportpharm Llc, this product is identified by NDC 85766-187 and is authorized under FDA application ANDA208017.

Identification & Billing

NDC Package Code
85766-187-25
Package Description
25 AMPULE in 1 CARTON / 5 mL in 1 AMPULE (85766-187-01)
Product Code
85766-187
11-Digit Billing Format
85766018725
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Lidocaine Hydrochloride
Non-Proprietary Name
Lidocaine Hydrochloride Anhydrous
Substance Name
Lidocaine Hydrochloride Anhydrous
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Epidural - Administration upon or over the dura mater.
  • Infiltration - Administration that results in substances passing into tissue spaces or into cells.
  • Intracaudal - Administration within the cauda equina.
  • Perineural - Administration surrounding a nerve or nerves.
Active Ingredient(s)
LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL
Pharmacologic Class
Usage Information
Lidocaine HCl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

Regulatory & Marketing

Labeler Name
Sportpharm Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA208017
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-18-2018
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85766-187-25 identifies a specific commercial package of 25 ampule in 1 carton / 5 ml in 1 ampule (85766-187-01) of Lidocaine Hydrochloride, a human prescription drug labeled by Sportpharm Llc. This injection, solution is formulated for epidural; infiltration; intracaudal; perineural use and contains lidocaine hydrochloride anhydrous as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sportpharm Llc on April 18, 2018. The current certification is valid through December 31, 2027.

How is this Sportpharm Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85766018725. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85766-187-25
11-Digit CMS (5-4-2)
85766-0187-25

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.